Cytodyn Inc (CYDY)

[shallwemaui]

So...what did everyone think of the conference call?

Items
1. Drexel is in complete charge of their 2 Stage iib tests, and CYDY can't make any commments, even about when they will begin. CYDY has delivered the vials to Drexel of Pro 140, which will be used in the testing. These 2 trials have funding through NIH.
2. Amarex is ready to begin recruiting for a treatment interruption study. This would take patients currently using HAARP, take them off their meds, and instead receive a weekly injection of Pro140. Viral loads would be tracked weekly. Any patient could be put back on HAARP if they did not react well to Pro140. Since this is not a "blind" or "double blind" study, it's possible data could be shared with big pharma as it is gathered. Sounds like they are expecting to interrupt patients for 4 to 8 week cycles.
3. Currently negotiating with 3 vet Universities to do the next round of cytofeline testing with a true feline version of the drug.
4. Company aware of need for inst investors and would also like to get off the OTC.
5. not able to tell us what the other Amarex testing will be. I still believe it will be something non-hiv related, either staph infections or breast cancer.